INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 12, 2024
Document Date
Feb 8, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
SING GEORGE L